A pilot evaluation of the safety and efficacy of memantine in patients with acute mania associated with bipolar I disorder.
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2012
At a glance
- Drugs Memantine (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 02 Mar 2012 Additional lead trial center identified as reported by ClinicalTrials.gov.
- 02 Mar 2012 Actual end date (1 Nov 2005) added as reported by ClinicalTrials.gov.
- 22 Dec 2007 Status change from in progress to completed according to ClinicalTrials.gov.